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This study describes the presence of 10 hemolysin orthologs in the genome of the opportunistic human
anaerobic pathogen Bacteroides fragilis, which is currently classified as a nonhemolytic bacterium. The
hemolysins were designated HlyA through HlyI plus HlyIII. All cloned hemolysin genes were able to confer
hemolytic activity to a nonhemolytic Escherichia coli strain on blood agar plates. Interestingly, HlyH was
found to be present in the genome of the B. fragilis NCTC9343 strain but absent in strains 638R, YCH46,
and Bacteroides thetaiotaomicron VPI-5482. The hemolysins HlyA, HlyB, and HlyIII were selected for
further characterization. HlyA, HlyB, and HlyIII were cytolytic to erythrocytes on liquid hemolytic assay.
When hlyA and hlyB were expressed together in a nonhemolytic E. coli strain, the strain showed enhanced
hemolytic activity on blood agar plates. Further analysis revealed that HlyA and HlyB have synergistic
hemolytic activity as detected by the liquid hemolytic assay. In addition, the two-component hemolysins
HlyA and HlyB form a protein-protein complex in vivo as determined by bacterial two-hybrid system assay.
The hlyB and hlyA genes are organized in an operon that is coordinately regulated by iron and oxygen.
Northern blot hybridization analysis revealed that hlyBA were expressed as a bicistronic mRNA induced
approximately 2.5-fold under low-iron conditions and repressed in iron-rich medium. The normal iron-
regulated expression of hlyBA mRNA was lost in the furA mutant strain. In contrast, the hlyA gene was also
expressed as a single mRNA in iron-rich medium, but its expression was reduced approximately threefold
under low-iron conditions in a Fur-independent manner. This suggests that hlyA alone is regulated by an
unidentified iron-dependent regulator. Moreover, the expression levels of hlyBA and hlyA were reduced
about threefold following oxygen exposure and treatment with hydrogen peroxide. Taken together, these
results suggest that iron and oxidative stress have an effect on the control of hlyBA and hlyA transcrip-
tional levels. A hlyBA mutant was constructed, and its hemolytic activity was greatly diminished compared
to those of the hlyIII mutant and parent strains. In addition, the hlyBA mutant had a significant
modification in colony morphology and growth deficiency compared to the parent strain. The implications
of these findings for the pathophysiology of B. fragilis in extraintestinal infections and competition in
ecological systems for this organism are discussed.
In the human colon (where at least 500 species of bacteria
have been reported to reside), Bacteroides species account for
about 30 to 40% of the total bacteria present in some people
(20, 26, 43, 54). Bacteroides spp. are also important opportu-
nistic human pathogens frequently isolated from anaerobic
infections (11). Within the Bacteroides family, Bacteroides fra-
gilis accounts for about 0.5% to 1% of total Bacteroides found
in the human large intestinal tract (11). Despite its low fre-
quency as a component of the intestinal microflora, B. fragilis
is by far the number one anaerobe isolated from anaerobic
infections. It accounts for 50 to 70% of all anaerobes isolated
from human infections, such as intra-abdominal infections, infec-
tions of the female genital tract, deep wounds, brain abscesses,
and bacteremia (4, 5, 11).
Although the whole arsenal of B. fragilis virulence determi-
nants is unclear, certain factors, such as capsular polysaccha-
rides, microbial adherence, production of proteases and neur-
aminidase, and inhibition of phagocytosis, are considered
important (43). The most studied B. fragilis virulence factor
associated with pathogenicity is the production of eight distinct
capsular polysaccharide complexes and their relation to ab-
scess formation (14, 15, 21). Though adherence, lipopolysac-
charide, and the production of neuraminidase, enterotoxin,
and proteolytic enzymes might play a role in B. fragilis patho-
genicity, they are not currently recognized to be strong deter-
minants of virulence (43).
There are other factors that are considered important in
infections by aerobes and facultative bacteria, but they have
been given little attention as far as their role in the pathogen-
esis of Bacteroides spp. is concerned. One such factor is the
ability of B. fragilis to produce hemolysins or cytolysins. He-
molysins have been reported to be powerful virulence deter-
minants in both gram-positive and gram-negative bacteria (24,
38, 51). Hemolysins are cytotoxic proteins that target cell mem-
branes, and their mechanisms of damaging membrane integrity
can be classified into three major groups: enzymatic activity,
pore-forming cytolysin, or surfactant (51). Many microbial he-
molysins offer an advantage to the bacteria by lysing and killing
incoming leukocytes, thus promoting survival of the microbe by
not only weakening the immune system but also by gaining
access to nutrients (24). Moreover, bacterial cytolysins/hemo-
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lysins play an important role in the equilibrium control of the
microbial ecosystem population associated with eukaryotic
hosts (9).
To date, no hemolysin has been characterized in B. fragilis
despite the fact that rare strains have a hemolytic phenotype
(18, 19). Nevertheless, a search of the B. fragilis genome se-
quence available at http://www.sanger.ac.uk/Projects/B_fragilis/
revealed the presence of 10 genes with homology to other
bacterial hemolysins (K. P. Robertson, C. J. Smith, and E. R.
Rocha, Abstr. 104th ASM Gen. Meet. Am. Soc. Microbiol.
2004, abstr. B-042, 2004). These findings were intriguing
because this anaerobic pathogen is classified as a nonhemolytic
bacterium (18, 19, 53). To clarify this apparent contradiction,
putative hemolysin genes found in the B. fragilis genome were
cloned and found to confer a hemolytic phenotype in a non-
hemolytic Escherichia coli strain (K. P. Robertson, C. J. Smith,
and E. R. Rocha, Abstr. Anaerobe 7th Biennial Cong. Anaer.
Soc. Am., abstr. II-O2, 2004). More recently, independent
studies have confirmed our observation that there is an
extensive number of putative hemolysin homologues in the
annotated genome sequences of B. fragilis NCTC9343 and
YCH46 (7, 22). Interestingly, this extensive number of
putative hemolysin genes does not correlate with the
“nonhemolytic” characteristic phenotype of most clinical
and laboratory strains of B. fragilis (18, 19, 53). Therefore,
these findings prompted us to characterize these putative
hemolysin genes in order to confirm their hemolytic
/cytolytic properties and role in B. fragilis pathophysiology.
It is important to mention that the only other cytotoxin that
has been studied in B. fragilis, fragilysin, is a Zn-metalloprotease
enterotoxin that is cytotoxic only to the human intestinal
carcinoma cell line HT29/C1. It specifically cleaves E-cadherin
of the zone adherens (40). Moreover, fragilysin is not mem-
branolytic to eukaryotic cells (50), nor does it seem to be a
virulence factor for extraintestinal infections (12). These
properties are much different than the characteristics of
hemolysins mentioned above.
In this study we report the characterization of B. fragilis
hemolysins HlyA, HlyB, and HlyIII. We also show that HlyA
and HlyB are two-component cytolysins that act together to
enhance their respective singular hemolytic activities against
erythrocytes. The hlyB and hlyA genes are organized in an
operon whose expression is differentially regulated by oxygen
and iron availability. In addition, we show that a hlyBA mutant
has a diminished hemolytic activity, altered colony morphol-
ogy, and a growth defect in vitro.
MATERIALS AND METHODS
Strains, media, and growth conditions. B. fragilis strains used in this study are
listed in Table 1. B. fragilis strain NCTC9343 is isogenic to ATCC 25285, and
henceforth ATCC 25285 was used in this study for experimental purposes when
required. Strains were routinely grown on BHIS (brain heart infusion supple-
mented with L-cysteine, hemin, and NaHCO3) agar. Rifamycin (20 g/ml), 100
g/ml gentamicin, 5 g/ml tetracycline, 10 g/ml erythromycin, and 25 g/ml
cefoxitin were added to the media when required. BHIS-blood agar plate (BAP)
is BHIS agar supplemented with 5% defibrinated blood from sheep, horses,
rabbits, cows (Gemini Bio-Products, Woodland, CA), or adult human volunteers.
For some experiments, bacteria were grown on a modified defined medium
supplemented with 5% defibrinated blood (DM-BAP) and on a semidefined
medium as previously described (33). E. coli strains were inoculated in Luria-
Bertani agar (L-agar) supplemented with 40 g/ml isopropyl-ß-D-thiogalactopy-
ranoside (IPTG) and 100 g/ml ampicillin. Human, horse, rabbit, sheep, or
bovine defibrinated blood (5%) (Gemini Bio-Products, Woodland, CA) was
added when appropriate. Glucose (0.2%) was added to L-agar for anaerobic
growth of E. coli.
Cloning of hemolysin genes. The hemolysin genes listed in Table 1 were
amplified by PCR using oligonucleotide primers designed to amplify the entire
open reading frame (ORF) plus an additional 15 to 20 nucleotides (nt) upstream
of the translation start site. Restriction sites were incorporated in the oligonu-
cleotide primers for direct cloning of the PCR products into the cloning vector
pUC19 in the same orientation as lacZ. hlyA through hlyG and hlyIII were
amplified from the B. fragilis 638R genome, while hlyH was amplified from the
ATCC 25285 genome. Plasmids were transformed into nonhemolytic E. coli
strains DH10B and screened for hemolytic activity on Luria-Bertani agar plates
incubated at 37°C for 24 to 48 h. In some experiments E. coli YMZ19 was used
as the host strain to confirm that the cloned genes were not interfering with
endogenous E. coli hemolytic activity. Hemolytic activity was detected by the
appearance of clear hemolytic zones around the bacterial colonies compared to
the control host strain carrying vector alone.
Measurement of hemolytic activity. Bacteria were harvested by centrifugation
at 10,000  g for 10 min. The cell pellet was washed with phosphate-buffered
saline (PBS) (50 mM phosphate buffer, pH 7.4, 150 mM NaCl) and resuspended
in 5 ml PBS. Cell lysates were obtained by using a French press. Whole cells and
cell debris were separated at 10,000  g for 30 min. Lysates were maintained at
4°C or stored at 70°C until needed. For liquid hemolytic assays, a protocol
modified from the methods of Bernheimer (1) and Rowe and Welch (38) was
used. Briefly, sheep red blood cells (RBCs) were washed with PBS and centri-
fuged at 400  g for 5 min. Washes were repeated until the supernatant was
visibly clear of hemoglobin. Erythrocyte suspensions were adjusted to 1% with
PBS supplemented with 0.1% bovine serum albumin. Crude extracts were ad-
justed to approximately 2 mg/ml of protein. Then, 0.5 ml of this solution was
incubated with 0.5 ml of the 1% erythrocyte suspension at 37°C. Samples were
centrifuged at 120 g for 7 min to remove undamaged RBCs. The concentration
of released hemoglobin is estimated by reading absorbance at 545 nm in a
spectrophotometer against a control background lysis solution (0.5 ml erythro-
cyte suspension with 0.5 ml PBS). A 100% hemolysis standard was obtained by
mixing 1 volume of distilled water containing 0.04% saponin and 1 volume of 1%
RBC suspension.
Construction of hlyBA and hlyIII deletion mutants. A 1.43-kb chromosomal
DNA fragment upstream from hlyB, including the first 57 nt within the N-
terminal region, was amplified by PCR and cloned into the unique BamHI site
of the E. coli-Bacteroides shuttle suicide vector pFD516 (42). Subsequently, a
1.68-kb DNA fragment downstream from hlyA, containing the last 155 nt of the
hlyA C-terminal region, was amplified by PCR and cloned into the unique EcoRI
site of the new construct pER-61. A 2.4-kb SstI fragment containing the tetra-
cycline resistance gene tetQ was cloned into the unique SstI site of pER-61 to
replace the internal 1.65-kb DNA fragment deleted from the hlyBA. The new
plasmid pER-62, containing the hlyBA::tetQ construct, was mobilized from E.
coli DH10B into B. fragilis 638R by triparental filter mating protocols (41).
Transconjugants were selected on BHIS agar containing 20 g of rifamycin per
ml, 100 g of gentamicin per ml, and 5 g of tetracycline per ml. Determination
of sensitivity to either tetracycline or erythromycin was carried out to identify
recombinants that were tetracycline resistant and erythromycin sensitive. South-
ern blot analysis was used to confirm the double-crossover genetic allele ex-
change of pER-62 into the B. fragilis chromosome. A transconjugant, BER-41,
containing the hlyBA::tetQ construct inserted into the B. fragilis 638R chromo-
some was selected for further studies.
To construct the hlyIII deletion mutant, a 520-bp internal DNA fragment from
hlyIII was deleted and replaced by a 2.1-kb cefoxitin resistance gene, cfxA.
Briefly, a 2.1-kb BamHI/EcoRI cfxA DNA fragment was cloned into the unique
BamHI and EcoRI sites of the suicide vector pFD516. Then, a 1.52-kb DNA
fragment upstream and a 1.60-kb DNA fragment downstream of the hlyIII gene
were cloned, respectively, into the unique SphI/BamHI and EcoRI restriction
sites of the pFD516/cfxA construct. The new plasmid, pER-64, carrying the
hlyIII::cfxA construct was mobilized into B. fragilis as described above.
Transconjugants were selected on BHIS agar containing 20 g of rifamycin per
ml, 100 g of gentamicin per ml, and 25 g of cefoxitin per ml. Sensitivity to
either cefoxitin or erythromycin was carried out to identify recombinants that
were cefoxitin resistant and erythromycin sensitive as described above. A B.
fragilis transconjugant, BER-45, containing the hlyIII::cfxA construct inserted
into the chromosome by double-crossover allelic recombination was selected for
further analysis. The hlyBA::tetQ hlyIII::cfxA double mutant strain, BER-46, was
obtained by mobilizing pER45 into strain BER-41 as described above.
Construction of a furA null mutant. Briefly, a 275-bp EcoRV/NruI DNA
fragment containing the first 25 N-terminal codons and 200 bp upstream of the
VOL. 74, 2006 BACTEROIDES HEMOLYSINS 2305
furA promoter region was ligated in frame to a 1.7-kb NruI/SstI DNA fragment
containing the last 17 furA codons and downstream region into pGEM-T (Pro-
mega, Madison, WI). The null mutation construct contained an in-frame dele-
tion of 363 nt from the furA gene. Next, a 2.1-kb BamHI/blunted EcoRI cfxA
gene was cloned into the BamHI/EcoRV sites of the new construct. Then, a
1.5-kb BamHI/BglII DNA fragment upstream of the furA promoter region
was cloned into the BamHI site of the new construct pER-9. A 5.5-kb
BamHI/SstI DNA fragment from pER-9 was cloned into the unique BamHI/
SstI sites of the suicide vector pFD516. The new plasmid, pER10, was mo-
bilized into B. fragilis 638R as described above. The mutant strain BER-2
containing the furA construct inserted into the chromosome by double-
crossover allelic recombination was grown under iron-replete and iron-lim-
iting conditions. Total RNA was extracted as described below. Real-time
reverse transcription-PCR of feoAB transcripts and feoAB::xylB transcrip-
tional fusion analysis were carried out to determine whether strain BER-2
lost the normal iron regulation uptake mechanism controlled by the ferric
uptake regulator FurA in other bacteria (23). Both methods showed that
feoAB mRNA expression was no longer repressed under high-iron conditions
compared to the parent strain, confirming the mutation and loss of normal
iron-responsive FurA regulation (data not shown).
Bacterial two-hybrid system assay. hlyB was cloned into the “bait” vector pBT
(BacterioMatch II; Stratagene, La Jolla, CA) in frame with cI. hlyA was cloned
into the “prey” vector pTRG in frame with the -subunit of RNA polymerase
according to the manufacturer’s instructions. The new constructs were cotrans-
formed into the E. coli two-hybrid system reporter strain derived from XL1-Blue
MRF kan [(mcrA)183 (mcrCB-hsdSMR-mrr)173 endA1 supE44 thi-1 recA1
gyrA96 relA1 lac [F proAB lacIqZM15 Tn5 (Kanr)] containing the HIS3-aadA
reporter cassette (Stratagene) and plated on selective screening medium. The
selective screening plate is histidine-dropout M9 agar supplemented with 0.5 mM
IPTG, 10 g/ml tetracycline, 25 g/ml chloramphenicol, and 5 mM 3-amino-
1,2,4-triazole. Culture media were prepared according to the manufacturer’s
instructions. Transformants from selective medium were grown on dual-selective
medium to confirm the interaction of the loaded “prey” and loaded “bait”
constructs by the activation of the dual reporter system assay. Dual-selective
TABLE 1. Strains and plasmids used in this study
Strain or




ATCC 23745 Clinical isolate, pleural fluid ATCC
ATCC 25285 Clinical isolate, appendix abscess (same as NCTC 9343) ATCC
VPI 2393 Unknown VPI
638R Clinical isolate, Rifr 30
BER-2 638R furA Rifr Cfxr This study
BER-41 638R hlyBA::tetQ Rifr Tetr This study
BER-45 638R hlyIII::cfxA Rifr Cfxr This study
BER-46 638R hlyBA::tetQ hlyIII::cfxA Rifr Tetr Cfxr This study
E. coli
DH10B Cloning host strain Invitrogen
YMZ19 MC1061 clyA::kan 47
Plasmids
pUC19 Cloning vector, Ampr Invitrogen
pGEM-T Cloning vector Promega
pFD516 Suicide vector, derived from deletion of pBI143 in pFD288 (Tetr) (Spr) (Ermr) 41
pER-2 1,047-bp dsDNA fragment amplified from 638R chromosome containing hlyF ORF was
cloned into the SphI/BamHI sites of pUC19
This study
pER-3 1,445-bp dsDNA fragment amplified from 638R chromosome containing hlyE ORF was
cloned into the SphI/BamHI sites of pUC19
This study
pER-9 3.2-kb DNA fragment from 638R containing a 363-bp in-frame deletion in furA plus 2.1-kb
cfxA gene cloned into the intergenic region cloned into pGEM-T
This study
pER-10 5.5-kb DNA fragment from pER-9 containing the furA construct was cloned into the
BamHI/SstI sites of pFD516
This study
pER-11 1,170-bp dsDNA fragment amplified from 638R chromosome containing hlyA ORF was
cloned into the BamHI/SstI sites of pUC19
This study
pER-12 933-bp dsDNA fragment amplified from 638R chromosome containing hlyB ORF was
cloned into the BamHI/SstI blunted sites of pUC19
This study
pER-13 1,477-bp dsDNA fragment amplified from 638R chromosome containing hlyG ORF was
cloned into the BamHI/SstI sites of pUC19
This study
pER-14 1,139-bp dsDNA fragment amplified from ATCC 25285 chromosome containing hlyH ORF
was cloned into the BamHI/SstI sites of pUC19
This study
pER-15 1,272-bp dsDNA fragment amplified from 638R chromosome containing hlyC ORF was
cloned into the BamHI/SstI sites of pUC19
This study
pER-16 363-bp dsDNA fragment amplified from 638R chromosome containing hlyD ORF was
cloned into the BamHI/SstI sites of pUC19
This study
pER-17 820-bp dsDNA fragment amplified from 638R chromosome containing hlyIII ORF was
cloned into the BamHI/SstI sites of pUC19
This study
pER-18 2,035-bp dsDNA fragment amplified from 638R chromosome containing hlyBA ORFs was
cloned into the BamHI/SstI sites of pUC19
This study
pER-61 Suicide vector containing a hlyBA construct in pFD516 This study
pER-62 2.4-kb SstI fragment containing the tetQ gene cloned into the unique SstI site of pER-61 to
make a hlyBA::tetQ construct in pFD516
This study
pER-64 Suicide vector containing a hlyIII::cfxA construct in pFD516 This study
a Rifr, rifampin resistance; Cfxr, cefoxitine resistance; Tetr, tetracycline resistance; Ampr, ampicillin resistance; Spr, spectinomycin resistance; Ermr, erythromycin
resistance. Antibiotic resistance expression in E. coli is indicated by drug resistance phenotypes shown in parentheses. dsDNA, double-stranded DNA.
b ATCC, American Type Culture Collection (Manassas, VA); VPI, Anaerobe Laboratory, Virginia Polytechnic Institute and State University (Blacksburg, VA).
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screening plates are the same as selective medium but 12.5 g/ml streptomycin
is added. Self-activation controls are the E. coli two-hybrid system reporter strain
carrying the following constructs: control 1, empty “bait” (pBT alone) cotrans-
formed with loaded “prey” (pTRG/HlyA); control 2, loaded “bait” (pBT/HlyB)
cotransformed with empty “prey” (pTRG alone).
RNA extraction and Northern blot hybridization. Bacteria were grown in
semidefined medium (SDM) as previously described (33). Hemin was replaced
by 5 g/ml protoporphyrin IX when required. Addition of 50 M 2,2-bipyridyl
and 100 M desferrioxamine was used to restrict iron availability in SDM.
Ferrous sulfate at 100 M was added as indicated in the text. For oxidative stress
experiments, cultures were grown to an A550 of 0.3 and treated with 50 M H2O2
for 5 min prior to total RNA extraction. To induce oxygen stress, cultures were
split in half, one half was kept anaerobically and the other half was shaken
aerobically at 250 rpm at a volume/flask ratio of 1/5 as previously described. Total
RNA extraction and Northern blot analysis of mRNA were carried out as
previously described (32), and internal fragments of hlyA and hlyB were used as
specific probes. Densitometry analysis of the autoradiograph was normalized to
the relative intensity of total 23S and 16S rRNA detected on the ethidium
bromide-stained agarose gel to correct for any loading differences.
RESULTS
Characterization of B. fragilis hemolysins was initiated follow-
ing the release of the B. fragilis NCTC9343 (ATCC 25285) and
638R genome sequences at http://www.sanger.ac.uk/Projects/B
_fragilis/. A search in the NCTC9343 genome revealed the
presence of 10 putative genes with homology to known bacterial
hemolysin genes available in the GenBank database. Henceforth
they are designated hlyA through hlyI plus hlyIII. Strain 638R has
all the same hemolysin genes as NCTC9343 except for hlyH
(Fig. 1 and data not shown). Moreover, hlyH was found to be part
of a 25-kbp region found in the NCTC9343 strain but absent in
strains 638R and YCH46. The hlyH chromosomal region is
flanked by insertion sequence elements, and we speculate that it
might be an unidentified putative pathogenicity island unique to
NCTC9343 strain (unpublished data). The release of the
complete genomic annotations of strains NCTC9343 (7) and
YCH46 (22) confirmed our previous assumption that putative
hemolysins are indeed present in the B. fragilis genome.
A comparison of the genetic organization of the putative
hemolysins in B. fragilis species revealed that hlyIII and hlyA
through hlyI are located in similar positions in the chromo-
somes of strains NCTC9343, 638R, and YCH46 (Fig. 1 and
data not shown). In contrast, the loci of hemolysin orthologs in
Bacteroides thetaiotaomicron VPI-5482 (55) are found at dif-
ferent locations compared to B. fragilis relative to the chromo-
some origin of replication oriC (Fig. 1). This suggests that there
have been major genetic rearrangements between these two
species. Both hlyF and hlyH homologues are missing in the B.
thetaiotaomicron VPI-5482 genome.
Hemolytic activity on BAP. When strains ATCC 25285,
638R, ATCC 23745, and VPI 2393 were grown on DM-BAP,
FIG. 1. Circular map showing the chromosomal locations of putative hemolysins within B. fragilis and B. thetaiotaomicron strains. The peptide
sequence for each hemolysin from strain 638R was used to identify the homologous peptide and respective locus tag number in B. fragilis
NCTC9343 and YCH46 and B. thetaiotaomicron VPI-5482. The locus tags for strain 638R are not shown, because the genome annotation has not
yet been released to public domain databases though the complete genome sequence is available at http://www.sanger.ac.uk/Projects/B_fragilis/. The
locus tag locations shown in parentheses were retrieved from references 7, 22, and 55 and from websites and an FTP site (http://www.sanger.ac.uk
/Projects/B_fragilis/, ftp://ftp.sanger.ac.uk/pub/pathogens/bf/, and http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db	nucleotide&val	60491031). The
percentage of amino acid identity of each gene product compared to that in strain 638R is shown in brackets. The genome length (in nucleotides) is
depicted in each panel below the respective strain name.
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FIG. 2. Hemolytic activity of B. fragilis strains grown on defined medium (DM) and BHIS agar supplemented with 5% defibrinated blood.
Plates were incubated anaerobically at 37°C for 5 days. Strain designations and animal blood source are shown in each panel.
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FIG. 3. Hemolytic activity of E. coli DH10B transformed with pUC19 carrying B. fragilis hemolysin genes. Bacteria were grown aerobically on
L-agar medium supplemented with 5% defibrinated blood (BAP) and 0.5 mM IPTG. For anaerobic growth, media were supplemented with 0.2%
glucose. E. coli carrying pUC19 alone was used as a control vector. All genes were amplified from B. fragilis 638R except for hlyH which was
amplified from ATCC 25285 strain. Hemolytic activity was determined by the appearance of a clear zone around the growth (beta-hemolysis) or
the appearance of a greenish hemolytic zone around the colonies (alpha-hemolysis).
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they produced beta-hemolysis after 3 to 5 days, but much
weaker activity was observed on BHIS-BAP during the same
period of incubation (Fig. 2). The early appearance of beta-
hemolytic zones on DM-BAP compared to BHI-BAP was an
indication that the production of hemolysin(s) might be under
the control of a nutritional/starvation mechanism. These re-
sults suggest that the apparent lack of the hemolytic phenotype
in clinical isolates of B. fragilis may be the consequence of a
short period of incubation typically used in clinical laboratory
diagnosis procedures. Strains ATCC 25285, 638R, and VPI
2393, were hemolytic for sheep, human, and horse red blood
cells on DM-BAP. In contrast, strain ATCC 23745 showed
strong hemolytic activity to horse RBCs but not to sheep and
human RBCs (Fig. 2). Interestingly, no apparent hemolytic
activity was detected on DM-BAP containing rabbit RBCs,
although strains ATCC 27285 and VPI 2393 produced dark
brown pigmentation. Furthermore, strains ATCC 23745 and
VPI 2393 showed strong hemolytic activity against horse and
rabbit RBCs on BHI-BAP. These findings suggest that the
hemolytic activity produced by B. fragilis might be influenced
by differences in strain background, the origin of the RBCs,
and growth conditions.
Cloning of hemolysin genes. To further characterize B. fra-
gilis hemolysins at a molecular level, hlyA through hlyH plus
hlyIII were cloned, overexpressed in the host strain E. coli
DH10B, and investigated for their ability to lyse RBCs. hlyI
was not characterized in this study. Figure 3 shows that com-
pared to controls with vector alone, all cloned genes conferred
beta-hemolytic phenotype to E. coli grown under anaerobic
conditions on BAP containing different animal RBCs. In con-
trast, there were differences in the hemolytic patterns when
cells were grown under aerobic conditions. For example, horse
RBCs did not show detectable hemolytic activity aerobically
but were highly susceptible to hemolysis anaerobically. On
bovine BAP, HlyG was beta-hemolytic under both aerobic and
anaerobic conditions, while HlyIII showed alpha-hemolysis
aerobically and stronger beta-hemolysis anaerobically. Inter-
estingly, HlyB and HlyA showed alpha-hemolysis on bovine,
rabbit, and sheep RBCs when expressed alone, but when ex-
pressed together, they showed ß-hemolysis, suggesting that
they may act synergistically under aerobic conditions. In con-
trast, in the absence of oxygen, HlyB, HlyA, and HlyBA were
beta-hemolytic. Taken together, these data clearly demon-
strate that major differences exist in the activity of these he-
molysins depending on the animal source of the RBCs and the
presence or absence of oxygen.
Analysis of HlyA and HlyB hemolytic activity in the E. coli
clyA mutant. At this point of the investigation, we were par-
ticularly interested in further investigating HlyA and HlyB
because our findings showed that they might act synergistically
(Fig. 3). Plasmids pER-11, pER-12, and pER-18 were trans-
formed into E. coli strain YMZ19 deleted for its cryptic, chro-
mosome-encoded, silent hemolysin ClyA (49). When HlyB and
HlyA were expressed together in pER-18, they showed syner-
FIG. 4. Hemolytic activity of E. coli YMZ19 (clyA::kan) expressing
B. fragilis hemolysins HlyB, HlyA, and HlyBA and the vector pUC19
alone. Cultures were inoculated on L-agar plates containing 5% defi-
brinated human blood plus 0.5 mM IPTG, 100 g/ml ampicillin, and 50
g/ml kanamycin. (A) Bacteria inoculated on top of the agar. (B)
Bacteria were stabbed through the blood agar.
FIG. 5. Liquid hemolytic assay. Crude extracts of E. coli carrying
HlyIII, HlyBA, and HlyB were used to determine hemolytic activity. E.
coli carrying vector pUC19 alone was used as a control. Sheep eryth-
rocytes were used in the liquid hemolytic assay as target cells. The
release of hemoglobin was measured in the supernatant at A540. Sym-
bols: ‚, HlyIII; F, HlyBA; , HlyA; ■, HlyB; E, HlyA plus HlyB; Œ,
pUC19. A lysis assay was carried out by mixing 0.5 ml of crude extract,
normalized to 2 mg/ml of protein, with 0.5 ml of the erythrocytes
suspension (see Materials and Methods for details). Data are the
averages for three experiments. All the standard errors were less than
5% and were therefore not included on the graph for clarity.
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gistic hemolytic activity on the surface of human BAP incu-
bated aerobically, but no activity when expressed alone com-
pared to the vector control strain (Fig. 4). In contrast, in
stabbed agar cultures, HlyBA and HlyA alone were hemolytic,
while HlyB itself showed no detectable hemolysis under the
same conditions compared to control vector. These findings
confirm our hypotheses that HlyA and HlyB have synergistic
interactions and that their activity was affected by exposure
to air.
Liquid hemolytic activity assay. Cytotoxicity (measured by
lysis of erythrocytes) of HlyBA, HlyB, HlyA, and HlyIII against
sheep RBCs was determined by the liquid hemolytic assay
(Fig. 5). Crude extracts of E. coli expressing HlyBA showed
strong hemolytic activity against sheep RBCs, as 50% lysis
occurred in just over 30 min of incubation. However, there was
a weaker hemolytic activity in crude extracts containing HlyB
or HlyA expressed alone. When crude extracts containing
HlyB and HlyA were mixed together before addition to RBCs,
hemolytic activity was restored similar to extracts containing
HlyBA. These results correlate with previous data and add
further support for the fact that HlyB and HlyA may have
synergistic properties. Under the same conditions, HlyIII lysed
50% of RBCs in about 20 min at 37°C similar to lysis obtained
with the HlyBA extract.
Protein-protein interaction between HlyA and HlyB. The
alignment of HlyA and HlyB amino acid sequences with other
bacterial hemolysins revealed that HlyB was homologous (34%
identity and 48.5% similarity) to the N-terminal half of Wolinella
succinogenes hemolysin and Vibrio anguillarum VAH5 (34), while
HlyA was homologous (33% identity and 45% similarity) to
the C-terminal region (Fig. 6). HlyA also showed strong ho-
mology to Porphyromonas gingivalis hemolysin (58% identity
and 69% similarity) and Prevotella melaninogenica hemolysin
PhyA (68% identity and 77.5% similarity). In Fig. 6 we show
the genetic organization of HlyA and HlyB, which are both
similar to V. anguillarum VAH5 and W. succinogenes hemo-
lysins, indicating that they might interact as if they were a large
single protein unit. These findings led us to think that HlyA
and HlyB would likely have the potential to form protein-
protein interactions. Thus, in order to further investigate this
hypothesis, experiments using the bacterial two-hybrid system
assay were carried out to determine whether HlyA and HlyB
would be able to form a complex in vivo. The data shown in
Fig. 7 confirm that the HlyB and HlyA form a complex in vivo.
FIG. 6. Diagram showing the genetic organization of B. fragilis (Bf) hemolysin genes hlyB and hlyA with other bacterial hemolysin orthologs.
Pg-hypot., Porphyromonas gingivalis W83 conserved hypothetical protein (GenBank accession no. AAQ66862); Pg-hly, P. gingivalis W83 hemolysin
A (AAQ66861); Pm-phyA, Prevotella melaninogenica hemolysin PhyA (AAB88217); Ws-hly, Wolinella succinogenes DSM 1740 hemolysin
(NP_908080); Va-VAH5, Vibrio anguillarum hemolysin VAH5 (AB189398). The gray arrows indicate the open reading frames and their respective
direction of transcription. The thin arrows depict mRNA transcript length. The bent arrow depicts the putative promoter region derived from Fig.
9. The conserved motif domains pfam01553 (acyltransferase) and COG3176 (hemolysin) present in respective gene products are depicted as boxes
underneath the panel and were obtained from a search in the collection of multiple-sequence alignments at http://www.ncbi.nlm.nih.gov/.
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Strains containing both the “bait” (pBT/HlyB) and “prey”
(pTRG/HlyA) constructs were able to grow on the selective
and dual-selective agar plate. In contrast, when the reporter
strain was carrying either empty “bait” or empty “prey,” as
control for self-activation, there was no growth on the selective
medium. This indicates that an interaction between HlyA and
HlyB occurred and activated the two-hybrid system, allowing
for growth on the selective reporter medium. Taken together,
the data presented above and in Fig. 3, 4, and 5 provide
evidence that the enhanced hemolytic activity of HlyA and
HlyB together is due to the formation of a protein-protein
complex.
Characterization of hlyBA and hlyIII deletion mutants.
When the hlyBA mutant strain was grown on BAP, hemolytic
activity was greatly diminished compared to the parent strain
(Fig. 8A). In contrast, the hlyIII mutant strain was not signif-
icantly different from the parent strain hemolytic zone. The
hlyBA hlyIII double mutant had a diminished, but not abol-
ished, hemolytic zone similar to the hlyBA mutant. These find-
ings show that the HlyBA hemolysin was responsible in large
part for the B. fragilis hemolytic activity on BAP. This also
suggests that a hemolysin(s) other than HlyBA and HlyIII is
still expressed and is yet to be further characterized. In addi-
tion, the hlyBA strain had a growth deficiency in SDM medium
compared to both the parent and hlyIII strain (Fig. 8C). The
growth rate of the hlyBA hlyIII double mutant was nearly
identical to that of the hlyBA strain. No significant difference in
growth rate was observed when bacteria were grown on rich
broth medium (data not shown). These findings correlate with
the data presented previously showing that B. fragilis had a
strong hemolytic activity on DM-BAP compared to BHIS-
BAP. Additional evidence that a disruption in HlyBA activity
affects the normal physiological homeostasis of B. fragilis was
the effect on colony morphology. When spotted on the surface
of a BHIS agar plate, the hlyBA mutant had a significant
modification in colony morphology compared to the parent
strain (Fig. 8B). hlyBA mutant colonies were irregular and
small in contrast to the circular and regular edges observed in
the parent strain. Lack of HlyIII did not apparently alter B.
fragilis colony morphology.
Effect of iron availability on hlyA and hlyB expression. As a
first step to understanding regulation of B. fragilis hemolysin
expression, hlyBA was used as a model. The hlyBA operon is
located immediately downstream from an iron-regulated heme
uptake outer membrane protein homolog similar to V. cholerae
HutA (16; also data not shown). Therefore, it was plausible
that hlyBA regulation was affected by iron availability. To study
this, a furA null mutant was constructed and the expression of
hlyA and hlyB mRNA was analyzed under iron-replete and
iron-limiting conditions. Northern blot hybridization analysis
revealed that hlyBA was expressed as a bicistronic mRNA and
up-regulated about 2.5-fold under low-iron conditions in the
parent strain. In contrast, the normal iron-regulated expression
of hlyBA mRNA in the parent strain was no longer repressed
under high-iron conditions in the fur mutant (Fig. 9A and B).
Interestingly, hlyA was also expressed as a single mRNA in
iron-rich medium, but hlyA mRNA expression was repressed
approximately threefold under iron-limiting conditions in a
Fur-independent manner. This suggests that hlyBA and hlyA
mRNAs are differentially regulated by iron and that hlyA alone
is also regulated by an unidentified iron-dependent regulator.
FIG. 7. E. coli two-hybrid system assay showing protein-protein interaction between HlyB and HlyA. E. coli reporter strain (Stratagene, La
Jolla, CA) cotransformed with pBT-HlyB (bait) and pTRG-HlyA (prey) constructs were grown on (A) nonselective plate and (B) dual-selective
plate. Self-activation controls are E. coli two-hybrid system reporter strain carrying the following constructs: control 1, empty “bait” (pBT alone)
cotransformed with loaded “prey” (pTRG/HlyA); control 2, loaded “bait” (pBT/HlyB) cotransformed with empty “prey” (pTRG alone). See
Materials and Methods for details on the bacterial two-hybrid system assay.
2312 ROBERTSON ET AL. INFECT. IMMUN.
Effects of oxidative stress on hlyA and hlyB expression. To
determine whether HlyA and HlyB are regulated by a change
in the cellular redox balance, cultures were exposed to atmo-
spheric oxygen and to the oxidant hydrogen peroxide. Figure
9C shows that the hlyA single RNA was expressed under an-
aerobic conditions, but its level was reduced about threefold
following oxygen exposure and treatment with H2O2. The low
level of the polycistronic hlyBA transcript was also reduced
under the same conditions. Taken together, these results sug-
gest that an oxidative stress insult affects the control of B.
fragilis hlyBA and hlyA transcription.
DISCUSSION
In this study we describe the presence of hemolysins in B.
fragilis, which is currently classified taxonomically as a nonhe-
molytic bacterium (18, 19, 53). The presence of at least 10
hemolysin orthologs in the B. fragilis genome suggests that they
may play an important role in extraintestinal infections and
possibly in the ecology and physiology of the intestinal tract. To
the best of our knowledge, there is no previous report on the
characterization of hemolysins in B. fragilis despite the fact that
rare clinical strains have been reported to have a hemolytic
phenotype in vitro (18, 19). Hemolysins/cytolysins are impor-
tant toxins that lyse neutrophils and other host cells which can
affect the immune response of the host and also provide a
source of nutrients for the invading microorganism (13, 24, 38,
51). Hemolysins/cytolysins in many bacteria are not only con-
sidered potent virulence factors but are also cytolytic/bacteri-
cidal factors used to inhibit other prokaryotes and eukaryotes
in highly competitive ecological systems (9). A classical exam-
ple of the participation of cytolysin in both pathogenesis and
ecological competitiveness is the two-peptide component cyto-
lysin (bacteriocin) of the gastrointestinal tract inhabitant En-
terococcus faecalis. Production of cytolysin by E. faecalis en-
hances lethality in human infections and animal models as well
as providing a competitive advantage over other gram-positive
bacteria in the intestinal tract (8, 9). In this regard, it is possible
that the extensive number of hemolysins/cytolysins in Bacte-
roides species not only play a role in the infectious process but
they also might contribute to their ability to dominate and take
over the colonization of the human large intestinal tract.
The findings presented in this study indicate that hemolysins
HlyA and HlyB are a two-component cytolysin. This is based
FIG. 8. Characterization of hlyBA and hlyIII mutants. A) Hemolytic activity produced by B. fragilis strains. Bacteria were grown on BHIS agar
supplemented with 5% human defibrinated blood. Plates were incubated for 8 days anaerobically. Bacteria were removed from the agar surface
with sterile cotton swab for clarity. B) Colony morphology of B. fragilis strains grown on agar. Each strain was inoculated on top of BHIS agar and
grown under anaerobic conditions. Strain designations are depicted above the colonies in panels A and B (WT, wild-type 638R parent strain). C)
Growth of B. fragilis strains on SDM. Bacteria were inoculated into fresh SDM from an overnight culture, and growth rate was measured at an
optical density (O.D.) of 550 nm. Data presented are averages from two independent experiments. Symbols: E, 638R parent strain; F, hlyBA
mutant strain; Œ, hlyIII mutant strain; ‚, hlyBA hlyIII double mutant strain.
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on results showing that when both components are expressed
together, there is a synergistic effect on hemolytic activity, and
there is a protein-protein interaction. However, it is not known
whether HlyA and HlyB protein complex formation occurs at
the cell membrane or occurs prior to attachment on the eu-
karyotic cell surface. Though two-component hemolysins are
produced by several bacteria (9, 25, 50, 52), B. fragilis HlyBA
does not share homology with the classical Serratia marcescens
family of two-component hemolysins (17) or bacterial pore-
forming toxins of the RTX (repeat-in-toxin) exoprotein family
(46). The mechanism of hemolytic activity of HlyBA is not
known, but because HlyB has a conserved phospholipid/glyc-
erol acyltransferase superfamily motif, we think that it might
possess functional features within this group of enzymes in-
volved in phospholipid biosynthesis (28, 48). Interestingly, the
HlyB and HlyA peptides are homologous, respectively, to the
acyltransferase and the hemolytic domains of hemolysins
found in microorganisms such as Vibrio anguillarum and W.
succinogenes. It is possible that a genetic mutation might have
occurred in Bacteroides and in the closely related anaerobe P.
gingivalis where HlyA and HlyB resulted from a split of a single
peptide unit into two distinct peptides. The reverse phenome-
non cannot be ruled out either. The reason for this is not
known, but we presume that the two separate peptides may
have other additional physiological properties directly interfer-
ing with bacterial physiology. In support of this is the fact that
the B. thetaiotaomicron hlyBA genes are arranged in a tran-
scriptional fashion similar to that in B. fragilis and the levels of
B. thetaiotaomicron hlyBA mRNA are more abundant in early
growth phase than the levels in later growth phase in vitro (44;
NCBI/Gene Expression Omnibus (GEO) database repository/
GEO database entry accession no. GSE2231).
Expression of HlyB and HlyA was shown to be differentially
and coordinately regulated by oxygen and iron availability. The
former represses hlyBA mRNA upon exposure to aerobic con-
ditions, and our hypothesis is that HlyBA may be a potential
virulence factor used by B. fragilis to injure and lyse host tissue
cells in order to obtain essential nutrients in an extraintestinal
anaerobic environment, such as an abscess. This is consistent
with the fact that B. fragilis is able to proliferate after the
establishment of anaerobic conditions at the site of infection
(35, 36, 37, 39). In general, anaerobic conditions in the infected
tissues are formed by the consumption of oxygen by facultative
bacteria often found associated with anaerobes in polymicro-
bial infections (35, 36, 37, 39). The effects of oxygen limitation
on hemolysin production and other virulence factors have been
demonstrated in several pathogenic bacteria (10, 27, 47). For
example, E. faecalis cytolysin/hemolysin CylLL and CylLS are
up-regulated (8.6-fold) at the transcriptional level under an-
aerobic conditions compared to the levels in the presence of
oxygen (10). The implications of anaerobic regulation of
HlyBA in the pathogenicity of B. fragilis correlate nicely with
the fact that the establishment of anaerobic infections in ex-
traintestinal tissues follows the depletion of oxygen at the site
of infection. Therefore, it is likely that HlyBA may contribute
to B. fragilis pathogenicity in a low-oxygen and low-iron envi-
ronment as discussed below.
Several studies have shown that B. fragilis is unable to syn-
thesize protoporphyrin macrocycle and has an essential re-
quirement for heme and nonheme iron (31, 45). This nutri-
tional requirement correlates with the expression and role
HlyBA might play to make possible bacterial access to iron and
heme under the low-iron conditions encountered in host tis-
sues. The production of hemolysins/cytolysins has been asso-
ciated with the ability of pathogenic bacteria to obtain heme as
a source of iron from lysed erythrocytes and other host cells
(13). In agreement, iron-limiting conditions regulate the syn-
thesis of hemolysins in many pathogenic bacteria (2, 3, 6, 23,
29). Thus, the iron-dependent regulation of hlyBA mRNA may
help B. fragilis to overcome the iron-limiting conditions im-
posed by a host’s iron-withholding mechanisms.
In conclusion, we showed in this study that B. fragilis
encodes several functional hemolysins not previously char-
acterized in this organism. Our studies on the synthesis and
regulation of hemolysins may help us to understand B. fra-
gilis pathogenicity and why this organism has a much greater
potential to cause infections than any other anaerobic spe-
cies that colonizes the human intestinal tract. In support of
the hypothesis that hemolysins are important for B. fragilis
virulence is a recent comparative genome analysis suggest-
ing that the presence of hemolysin-like proteins and capsu-
lar polysaccharides may explain the difference in pathogenic
FIG. 9. Autoradiograph of Northern hybridization of total RNA. A
and B) B. fragilis 638R and isogenic fur mutant were grown to mid-log
phase in SDM containing 100 M FeSO4 for iron-replete conditions
(Fe) and SDM containing 50 M 2,2-bipyridyl and 100 M desfer-
rioxamine to impose iron-limiting conditions (Fe). Protoporphyrin
IX (PpIX) was added to the medium as a source of tetrapyrrole
macrocycle. The probe was an internal fragment from hlyA (panel A)
or hlyB (panel B). The positions of the hlyA and hlyB mRNA compo-
nents are indicated. The asterisk depicts the 16S compression region
on the filter membrane. (C) B. fragilis 638R was grown in SDM sup-
plemented with 5 g/ml hemin and exposed to different oxidative stress
conditions. The probe was an internal fragment of hlyA.
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potentials between the two closely related species B. fragilis
and B. thetaiotaomicron (22).
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